Company Filing History:
Years Active: 2016-2019
Title: Elien B Engels: Innovator in Cardiac Resynchronization Therapy
Introduction
Elien B Engels is a prominent inventor based in Maastricht, Netherlands. She has made significant contributions to the field of cardiac resynchronization therapy (CRT) through her innovative patents. With a total of 2 patents, her work focuses on optimizing cardiac pacing techniques to improve patient outcomes.
Latest Patents
One of her latest patents is titled "Electrogram-based control of cardiac resynchronization therapy." This invention involves controlling the delivery of CRT by adjusting ventricular pacing according to a sequence of different values of A-V delay or V-V delay. The method includes acquiring electrograms from respective vectors and determining QRS amplitude or area based on these electrograms. By identifying target changes in QRS parameters, the implantable medical device can deliver optimal pacing to enhance CRT effectiveness.
Another notable patent is the "Method and apparatus for optimization of cardiac resynchronization therapy using vectorcardiograms derived from implanted electrodes." This invention describes a cardiac resynchronization pacemaker and a method for adjusting its settings. The process involves deriving a vectorcardiogram from implanted electrodes, analyzing it, and deriving optimal CRT pacing parameters. The pacemaker is equipped with a processor that performs these adjustments to ensure effective therapy.
Career Highlights
Elien B Engels has worked with leading organizations in the medical field, including Medtronic, Inc. and Universiteit Maastricht. Her experience in these institutions has allowed her to develop and refine her innovative ideas in cardiac therapy.
Collaborations
Throughout her career, Elien has collaborated with notable professionals, including Alfonso Aranda Hernandez and Frits W Prinzen. These partnerships have contributed to her success and the advancement of her inventions.
Conclusion
Elien B Engels is a trailblazer in the realm of cardiac resynchronization therapy, with her patents paving the way for improved medical devices and patient care. Her dedication to innovation continues to impact the field positively.